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Neutrophils contain granules loaded with antimicro-
bial proteins and are regarded as impermeable
organelles that deliver cargo via membrane fusion.
However, during the formation of neutrophil extracel-
lular traps (NETs), neutrophil elastase (NE) translo-
cates from thegranules to thenucleusviaanunknown
mechanism that does not involve membrane fusion
and requires reactive oxygen species (ROS). Here,
we show that the ROS triggers the dissociation of
NE from a membrane-associated complex into
the cytosol and activates its proteolytic activity in a
myeloperoxidase (MPO)-dependent manner. In the
cytosol, NE first binds and degrades F-actin to arrest
actin dynamics and subsequently translocates to the
nucleus. The complex is an example of an oxidative
signaling scaffold that enables ROS and antimi-
crobial proteins to regulate neutrophil responses.
Furthermore, granules contain protein machinery
that transports anddelivers cargo acrossmembranes
independently of membrane fusion.
INTRODUCTION
Neutrophils are the foot soldiers of the innate immune system
as they are plentiful, short-lived, and armed with antimicrobial
effector strategies. They are the first immune cells to arrive at a
site of infection and are ready to respond, carrying presynthe-
sized antimicrobial effectors and the enzymes needed to mount
an intense burst of reactive oxygen species (ROS) (Amulic et al.,
2012). Antimicrobial effectors are synthesized during neutrophil
development and are stored in specialized membrane-bound
vesicles called granules. Granules contain different cargo de-
pending on when they were synthesized. This results in a contin-
uum of granule contents that are classified into four categories:
secretory vesicles and azurophilic, specific, and gelatinase gran-
ules (Borregaard, 2010).
Granule membranes are regarded as impermeable barriers
that allow for delivery of their cargo through membrane fusion.Neutrophils ingest and kill microbes intracellularly through
phagocytosis. During this process, microbes are enclosed in
a membrane compartment known as the phagosome, where
exposure to ROS and antimicrobial effectors eliminates patho-
gens. The antimicrobial load of granules is delivered to the phag-
osome by fusion of the granule and phagosomal membranes.
In addition, granules can fuse with the plasma membrane to
release granule cargo extracellularly through degranulation.
In contrast to this classical view, an antimicrobial strategy
that involves some unconventional cell biology was recently
uncovered. Neutrophils were shown to release web-like struc-
tures known as neutrophil extracellular traps (NETs) that
ensnare and kill a variety of microbes. NETs are composed of
decondensed chromatin and a subset of granule and cyto-
plasmic proteins (Brinkmann et al., 2004). Patients and animals
carrying mutations in the genes required for NET formation
are more susceptible to infections (Brinkmann and Zychlinsky,
2012). On the other hand, unregulated NET release or lack
of NET degradation is linked to several diseases, including
cystic fibrosis, preeclampsia, autoimmunity, and vascular dis-
eases (Garcia-Romo et al., 2011; Hakkim et al., 2010; Kessen-
brock et al., 2009; Khandpur et al., 2013; Lande et al., 2011;
Papayannopoulos et al., 2011; Villanueva et al., 2011). There-
fore, it is critical to understand the mechanisms that regulate
NET formation.
NETs form in response to specific stimuli through a unique
form of cell death called ‘‘NETosis.’’ The nuclear material ex-
pands while chromatin decondenses and the nuclear envelope
disintegrates. The cytoplasmic membrane ruptures, liberating
the NETs (Fuchs et al., 2007). A fraction of neutrophils have
also been reported to release NETswithout dying, leaving behind
cytoplasts that continue to ingest microbes (Pilsczek et al., 2010;
Yipp et al., 2012).
A factor that is known to be critical for NET formation is neutro-
phil elastase (NE) (Papayannopoulos et al., 2010). This serine
protease is stored in azurophilic granules and contributes
to antimicrobial activity in the phagosome. During NET forma-
tion, NE translocates from the granules to the nucleus and
partially cleaves histones to promote chromatin decondensation
(Papayannopoulos et al., 2010). The mechanism of NE release
from azurophilic granules remains unknown and does not involve
membrane fusion.Cell Reports 8, 883–896, August 7, 2014 ª2014 The Authors 883
Figure 1. ROS and MPO Are Required for
NE Translocation during NETosis
(A) Single confocal microscopy images of neutro-
phils from control, CGD, and DMPO donors. The
neutrophils were stimulated for 60 min with
C. albicans, immunolabeled for NE (red), and
stained for DNA (Draq5, blue). Arrows indicate
nuclear NE. Scale bars, 20 mm.
(B) NE release into the cytosol during NETosis
measured by ELISA in cytosolic extracts derived
from naive neutrophils alone (N) or PMA-activated
neutrophils (NP) from control and DMPO donors.
NE in the cytosol normalized to the total amount of
NE in the cytoplasmic extract of each sample at
time 0. Error bars indicate SD in triplicate samples;
***p < 0.001 between control and DMPO samples
at 60 min. Cytoplasmic extracts were made by
nitrogen cavitation, without detergent, to keep the
granule membranes intact. Cytosolic extracts
were made by ultracentrifugation of cytoplasmic
extracts.
(C) Immunoblot of the degradation of exogenous
histone H4 by cytoplasmic extract from naive
neutrophils alone (N) or PMA-activated (NP) con-
trol and DMPO neutrophils. The cells were acti-
vated for the indicated time durations and H4 was
incubated with the cytoplasmic extracts for 3 hr.
(D) Immunoblot against endogenous histone H4 in
total cell lysates of naive neutrophils alone (N) from
control or DMPO donors. Naive neutrophils (N) or
stimulated with PMA (NP) or C. albicans (NC) for
the indicated durations in the presence (+NEi) or
absence of NEi. Full-length (H4, arrow) and pro-
teolytically processed H4 (H4*, red arrow). C,
C. albicans alone.
See also Figure S1.ROS are crucial for effective antimicrobial responses. Patients
with chronic granulomatous disease (CGD), who are deficient
in NADPH oxidase activity, and individuals who are completely
deficient in myeloperoxidase (DMPO; Figure S1A) are suscepti-
ble to opportunistic infections, particularly to fungal pathogens
(Nauseef, 2007). Neutrophils from these patients fail to form
NETs when stimulated with physiological NET stimuli such as
fungi or the ROS agonist phorbol myristate acetate (PMA) (Fuchs
et al., 2007; Metzler et al., 2011).
Upon stimulation, neutrophils rapidly activate the NADPH ox-
idase to generate superoxide, a highly reactive molecule that
dismutates to hydrogen peroxide (H2O2) (Winterbourn and Ket-
tle, 2013). H2O2 is consumed by MPO to produce hypochlorous
acid (HOCl) and other oxidants. MPO is also required for NET for-
mation, as shown in donors with complete MPO deficiency, but
its role remains unclear (Metzler et al., 2011). Although ROS are
cytotoxic, they are also important signaling mediators that regu-
late protein function via the oxidation of specific amino acid res-
idues (Nathan, 2003; Tonks, 2005;Winterbourn, 2008). However,884 Cell Reports 8, 883–896, August 7, 2014 ª2014 The Authorssince ROS are highly reactive, short-lived
molecules, it is unclear how they are able
to produce specific cellular responses. In
particular, during NET formation, it is not
known whether and how ROS regulatethe selective translocation of NE from the granules to the nu-
cleus. Furthermore, as the nucleus begins to decondense during
NET formation, neutrophil chemotaxis is arrested through an
unknown mechanism.
Using primary human neutrophils and proteins purified from
healthy individuals and patient donors, we show that NE translo-
cation involves a mechanism that does not require membrane
fusion and regulates protease activation and actin dynamics.
RESULTS
ROS and MPO Are Required for NE Release from
Granules
Since ROSproduction precedes NE translocation to the nucleus,
we tested whether ROS and MPO are required for this process.
In contrast to neutrophils from healthy ‘‘control’’ donors, in neu-
trophils derived from CGD and DMPO donors stimulated with
Candida albicans (Figure 1A) or PMA (Figure S1B), NE failed to
translocate to the nucleus and remained in granules.
We examined whether NE is first released from the granules
into the cytosol. We stimulated neutrophils with PMA, lysed
them at different time points, and isolated cytoplasm containing
the soluble cytosol and granules. We obtained cytosol, which
contains only the released soluble proteins, by ultracentrifuga-
tion of cytoplasm to remove granules, and monitored the pres-
ence of NE in these subcellular fractions by ELISA. NE was
detected transiently in the cytosol of control neutrophils 60 min
after activation (Figure 1B). Consistent with previous observa-
tions (Papayannopoulos et al., 2010), NE disappeared from the
cytosol 120min after activation, as it translocated to the nucleus.
In contrast, in DMPO neutrophils, NE was not detected in the
cytosol.
NE proteolytic activity in the cytosol from naive and activated
neutrophils was also detected by adding purified recombinant
histone H4 to these fractions. H4 is the relevant NE substrate
during NETosis. Background partial H4 cleavage was detected
in cytosol from naive neutrophils, which may be due to cytosolic
proteases. Notably, H4 was completely degraded when incu-
bated with cytosol from control neutrophils stimulated with
PMA for 30 min (Figure 1C). This is consistent with the presence
of active NE in the cytosol, since we previously showed that this
protease degrades soluble H4 processively (Papayannopoulos
et al., 2010). The peak of processive H4 degradation coincided
with the highest cytosolic NE concentration detected by ELISA
(Figure 1C). Recombinant H4 degradation was blocked by the
small-molecule, cell-permeable NE inhibitor (NEi) GW311616A
(Macdonald et al., 2001), but not by an inhibitor of the related
azurophilic granule protease, cathepsin G (CGi; Figure S1E),
indicating that H4 was degraded by active NE in the cytosol.
In contrast, only background protease activity was detected
in the cytosol of DMPO neutrophils, suggesting that MPO is
required for the release of proteolytically active NE from the gran-
ules into the cytosol during NET formation.
Since the final destination of NE during NETosis is the nucleus,
where it targets core histones, we examined the degradation
of endogenous neutrophil nuclear H4 in activated control and
DMPOneutrophils. HistoneH4was not cleaved inDMPOneutro-
phils stimulated with C. albicans (Figure 1D) or DMPO and CGD
neutrophils stimulated with PMA (Figures S1C and S1D). Thus,
ROS and MPO are required for the release of NE to the cytosol
and its subsequent translocation to the nucleus during NETosis.
Importantly, the route of NE translocation via the cytosol hinted
that the translocation was driven by a novel MPO-dependent
mechanism that does not involve membrane fusion.
We also examined whether this mechanism is implicated in
the delivery of NE to the phagosome, which involves membrane
fusion. Notably, NE cleaves bacterial virulence factors such as
the Shigella flexneri IpaB protein inside the phagosome, prevent-
ing microbial escape from the phagosome (Weinrauch et al.,
2002). Therefore, we tested whether MPO is required for
NE function in the phagosome by incubating neutrophils with
S. flexneri and examining the cleavage of the phagocytosed
IpaB. IpaB was cleaved equally well by control neutrophils in
the absence and presence of a pharmacological MPO inhibitor
(ABAH; Figure S1F). Furthermore, neutrophils derived from a
DMPO donor degraded IpaB with comparable efficiency. As ex-
pected, IpaB degradation was prevented in control and DMPOneutrophils when NE activity was inhibited pharmacologically
by NEi (Macdonald et al., 2001). Thus, this mechanism for
NE release appears to be specific to NET formation and not
phagocytosis.
Azurophilic Granules Contain the Machinery for NE
Release
Next, we investigated whether the factors that mediate NE
release are contained in azurophilic granules. We isolated intact
azurophilic granules by nitrogen cavitation and discontinuous
Percoll density gradient centrifugation, which separates this
granule subtype from other neutrophil granules and cytosol
(Kjeldsen et al., 1994). To detect release of NE, we incubated
granules with exogenous b-galactosidase and monitored its
degradation by loss of b-galactosidase activity. To avoid varia-
tions in protease content between different granule preparations,
we normalized the concentration of granules based on the con-
tent of NE and CG as measured by ELISA and immunoblotting.
First, we testedwhether H2O2was sufficient to trigger NE release
in this system. Several lines of evidence suggest that H2O2, the
substrate of MPO, is a key ROS intermediate in NET formation,
since it is sufficient to stimulate NET formation in neutrophils
(Fuchs et al., 2007) and in a cell-free assay where neutrophil
nuclei are incubated with cytoplasmic extracts containing azuro-
philic granules in vitro (Figure S2A; Papayannopoulos et al.,
2010). Moreover, catalase, which consumes H2O2, blocks NET
formation (Fuchs et al., 2007; Parker et al., 2012). Azurophilic
granules from control donors degraded b-galactosidase upon
treatment with H2O2, indicating that active proteases were
released and gained access to the substrate in the absence of
detergent (Figures 2A and S2B). NEi and CGi together, but not
individually, decreased b-galactosidase degradation, indicating
the release of multiple active proteases (Figure S2C). Surpris-
ingly, H2O2 did not disrupt the overall integrity of the granules,
as reflected by the conservation of the granule signature in a
CASY impedance counter, which measures membrane integrity
by the exclusion of electrical current (Figure 2B). This observation
suggested that themechanismofNE release does not involve the
dissolution of granule membranes, but rather a novel means
of release from intact granules. Moreover, H2O2 failed to induce
b-galactosidase degradation in DMPO granules, suggesting
that MPO is required for NE release (Figures 2A and S2B).
To examine whether H2O2 plays a role in activating proteases
in this assay independently of their release, we tested b-galacto-
sidase degradation after dissolving granule membranes with
detergent to expose the substrate to the proteases. In control
granules, addition of detergent did not induce b-galactosidase
degradation, but proteolytic activity required H2O2 even in
the absence of membranes (Figures 2A and S2B). In contrast,
H2O2 treatment failed to activate proteases in DMPO granules
treated with detergent. Therefore, the factors that drive protease
activation and release in response to H2O2 are localized in azur-
ophilic granules, and MPO is critical for both processes.
Isolation and Identification of an Azurophilic Granule
Complex
To identify the factors that mediate NE release and activation,
we probed for NE-binding partners in azurophilic granules byCell Reports 8, 883–896, August 7, 2014 ª2014 The Authors 885
Figure 2. Azurophilic Granules Contain the
Azurosome Complex
(A) b-galactosidase activity against X-gal after in-
cubation with azurophilic granules from a control
and a DMPO donor in the absence or presence
of H2O2 and/or detergent. Error bars indicate SD
in triplicate samples; ***p < 0.001 between the
indicated samples.
(B) CASY impedance cell counter analysis of
azurophilic granules, either untreated or treated
with H2O2 or with detergent.
(C) Coomassie stain of azurophilic granule lysates
before immunoprecipitation (IP, left), or proteins
immunoprecipitated with anti-NE (IP a-NE) or
control anti-MMP9 antibody (mock) from isolated
azurophilic granules untreated or treated with
hydrogen peroxide (H2O2) (IP, right). LTF, lacto-
ferrin; MPO, myeloperoxidase; AZU, azurocidin;
CG, cathepsin G; ECP, eosinophil cationic protein;
LYZ, lysozyme; HD1, defensin-1.
(D) IP of solubilized azurophilic granule extract
with rabbit anti-BPI or rabbit anti-NE, followed by
immunoblotting with a mouse anti-BPI antibody.
(E) Coomassie stain of purified azurosome com-
plex (fractions 19–22 from Figure S3B, pooled and
concentrated). PR3, proteinase 3.
See also Figure S2.immunoprecipitation.We isolated azurophilic granules fromcon-
trol neutrophils, solubilized them with detergent, and immuno-
precipitated proteins with an antibody against NE or a control
mock antibody against matrix metalloproteinase 9 (MMP9),
a protein that is stored in gelatinase granules. Anti-NE, but
not the control antibody, selectively coimmunoprecipitated
a granule protein complex containing MPO, azurocidin (AZU),
CG, eosinophil cationic protein (ECP), defensin-1 (HD1), lyso-
zyme (LYZ), and lactoferrin (LTF) (Figure 2C). LTF is primarily a
specific granule protein, but it has also been found in azuro-
philic granules (Lominadze et al., 2005). Western blot analysis
confirmed the specific immunoprecipitation of several of these
proteins (see Figures 4B–4D). To further confirm the specificity
of the immunoprecipitation, we immunoblotted against an azur-
ophilic granule protein that was not immunoprecipitated. The
bactericidal/permeability-increasing protein (BPI) was detected
only upon immunoprecipitation with an antibody against BPI,
and not with an anti-NE antibody (Figure 2D).
Interestingly, treatment of intact granules with H2O2 prior to
solubilization and immunoprecipitation led to the dissociation
of this complex, as significantly less protein was coimmunopre-886 Cell Reports 8, 883–896, August 7, 2014 ª2014 The Authorscipitated (Figure 2C). In order to investi-
gate the effects of oxidation on the com-
plex, we isolated azurophilic granules
from peripheral blood neutrophils of
healthy human donors and purified the
complex by size-exclusion chromatog-
raphy, probing the fractions for NE and
MPO (Figures S3A and S3B). The com-
plex eluted at a higher molecular weight
than purified MPO (Figure S3B) and con-tained the same proteins that coprecipitatedwith NE as detected
by mass spectrometry (Figure 2E). We also identified proteinase
3 (PR3), a related azurophilic granule protease with high homol-
ogy to NE (Korkmaz et al., 2008), in the purified complex. NE and
MPO are present in the complex at a ratio of 2:1. Similarly to the
immunoprecipitated complex (Figure 2C), the purified complex
dissociated when pretreated with H2O2, as we did not detect
these proteins in the complex-containing fractions by mass
spectrometry, ELISA, or enzymatic activity (Figures S3C–S3E).
This observation hinted that H2O2 may regulate the function of
this azurophilic granule complex by modulating the association
of its components. To facilitate the nomenclature, we refer to
this azurophilic granule complex as the ‘‘azurosome.’’
NE and MPO Localize to the Membrane in a Subset of
Azurophilic Granules
To investigate the localization of the complex in neutrophils, we
labeled MPO and NE with immunogold and performed transmis-
sion electron microscopy. We found three subsets of granules in
naive and activated neutrophils of control and MPO-deficient
neutrophils. In one subset, NE and MPO localized to the granule
membrane in a radial pattern (Figure 3A, arrows). In the second
subset of granules, NE and MPO were predominantly in the
lumen (Figure 3B). In a third subpopulation, MPO and NE
localized to both the membrane and the lumen (mixed). Our ob-
servations are consistent with similar findings in promyelocytes
(Egesten et al., 1994) and confirm the heterogeneity of azuro-
philic granules (Borregaard, 2010). Quantitation of electron mi-
crographs showed that MPO and NE were localized exclusively
in the membrane in 50% of labeled granules and exclusively in
the lumen in 25%. In the remaining 25%, the proteins were local-
ized in both themembrane and the lumen (Figure 3C). These data
are consistent with the idea that azurosome components localize
in the membrane in a subset of azurophilic granules, but they do
not constitute a quantitative assessment of protein association
and abundance.
To determine whether the azurosome is exposed on granule
membranes, we incubated isolated native azurophilic granules
with an antibody against MPO or a control antibody against
BPI, a protein that is not found in the azurosome (Figure 2D)
and is not expected to be on the membrane. We centrifuged
themixture of granules and antibodies over a discontinuous Per-
coll gradient and isolated the intact azurophilic granules from
the appropriate gradient fraction. Only the antibody against
MPO was detected in the azurophilic granule fraction, and the
antibody against BPI did not cosediment, confirming that the
granule membranes were intact and undamaged, shielding BPI
from antibody recognition (Figure 3D). Neither of the two anti-
bodies sedimented in the absence of granules. These results
indicated that MPO is exposed on the surface of azurophilic
granules and is accessible to antibodies added externally.
Consistently, treatment of azurophilic granules from naive
control neutrophils with proteinase K in the absence of detergent
partially degradedMPO and AZU, indicating that in naive neutro-
phils, a fraction of MPO and AZU are exposed at the surface
of granules (Figure 3E). AZU was better protected than MPO,
suggesting that the former may be less exposed. BPI was
completely protected from degradation, corroborating that
the granules were intact and the exposure of MPO and AZU
was not due to damaged granule membranes. This was further
confirmed by impedance measurement of membrane integrity
(not shown).
Together, these data suggest that naive neutrophils contain a
subset of azurophilic granules that harbor the azurosome on their
membranes and are poised to release proteases upon oxidative
stimulation. The association with membranes does not seem
to require MPO, since NE localizes to granule membranes in
both control and DMPO neutrophils (Figure 3A). Rather, MPO
is required for the ability of the complex to release proteins
across membranes.
H2O2 Triggers the Dissociation of Granule Proteases
from the Complex
The results shown in Figure 2C suggested that oxidants may
regulate NE release from the granule by modulating the newly
identified membrane-associated complex. To address whether
H2O2 is required for NE release during NETosis in neutrophils,
we tested whether depleting intracellular H2O2 with PEG-cata-
lase, which is taken up by the cells and consumes H2O2, wouldblock NE release into the cytosol. PEG-catalase completely
blocked NE release, indicating that H2O2 regulates this process
and is required for NETosis (Figure 4A).
Next, we investigated how H2O2 triggers NE release. We pre-
viously found that during NETosis, NE translocates to the nu-
cleus while MPO remains in the granules (Papayannopoulos
et al., 2010). The association of NE with MPO in granules of naive
neutrophils suggested that H2O2 stimulation may trigger their
dissociation. Indeed, by immunoprecipitating the azurosome
with an anti-NE antibody and immunoblotting, we found that in
azurophilic granules treated with H2O2, MPO dissociated from
NE (Figure 4B). Importantly, MPO dissociation did not require
NE activity, since it was not blocked by a cocktail of protease in-
hibitors (PIs) against NE, CG, and other proteases (Figure 4B).
The disappearance of immunoprecipitated MPO was not due
to degradation or lack of recognition by the anti-MPO antibody,
since MPO was detected in the lysate prior to immunoprecipita-
tion in all samples. In addition, MPO dissociated from NE when
the enzymatic activity of MPO was blocked pharmacologically
with ABAH. Since ABAH does not completely suppressMPO ac-
tivity (Figure S4A), we tested the ability of HOCl, themain product
of MPO in these reactions, to drive complex dissociation. NE and
MPO remained bound upon treatment of azurophilic granules
with HOCl (Figure S4B), indicating that H2O2 likely is sufficient
to drive dissociation. However, one cannot rule out the possibil-
ity that dissociation is driven by other MPO oxidative products.
We also examined the dissociation of other azurosome pro-
teins after treatment of azurophilic granules with H2O2 and found
that NE dissociates from MPO and LYZ, but remains bound to
CG and AZU (Figure 4C). These data further confirm that the
loss of MPO is due to dissociation from the complex, and not
to inefficient immunoprecipitation, as these other proteases are
pulled down with comparable efficiency. Consistent with these
in vitro observations, we found a similar molecular pattern for
release in activated neutrophils isolated from human control do-
nors, where a complex of NE, CG, and AZU, but not MPO, coim-
munoprecipitated from the cytosol at 60 min poststimulation
(Figure 4D). Moreover, NE and CG translocated to the nucleus
simultaneously in neutrophils activated with PMA (Figure 4E) or
C. albicans (Figure S4C). In contrast, MPO and PR3 remained
in granules during this early phase of NET formation (Papayanno-
poulos et al., 2010). Therefore, during NET formation, H2O2 trig-
gers the dissociation of the complex with MPO remaining in the
granules and a protease subcomplex selectively released into
the cytoplasm.
The Azurosome Mediates MPO-Dependent Protein
Release from Intact Granules
To address the role of MPO in NE release, we tested the ability of
purified complex from healthy control and DMPO human donors
to release the contents of calcein-loaded synthetic liposomes
in the absence of other membrane proteins. Inside liposomes,
calcein is packed at high concentrations that quench its fluo-
rescence. Calcein release alleviates quenching, causing an in-
crease in calcein fluorescence.
Incubating the calcein-loaded liposomes with a purified con-
trol complex resulted in calcein release in a dose-dependent
manner (Figure 5A). The data fitted to a sigmoidal dose-responseCell Reports 8, 883–896, August 7, 2014 ª2014 The Authors 887
Figure 3. NE and MPO Localize to the Membrane in a Subpopulation of Granules
(A) Immunoelectronmicrographs of granules from control orDMPO neutrophils, naive or stimulated for 60min with PMA and labeled with antibodies against MPO
and NE coupled to 6 and 12 nm particles. Arrows indicate the membrane localization of NE and MPO.
(B) Representative immunoelectron micrographs of azurophilic granules exhibiting localization of MPO and NE in the granule lumen. Control neutrophils were
either left untreated or stimulated with PMA for 60 min before fixing and immunogold labeling for MPO and NE.
(C) Average distribution per single cell of granules with the indicated MPO and NE localization in electron micrographs from eight naive and 13 PMA activated neu-
trophils; 114and153granules, respectively,werecounted.Errorbars indicateSDwithineachgranulegroup.NonparametricANOVA formediandifferences, p=0.003.
(D) Azurophilic granules incubated with rabbit IgG against MPO or BPI, fractionated by centrifugation over a discontinuous Percoll gradient of 1.05, 1.09, and
1.12 g/ml density. The soluble (S) top layer and the 1.09/1.12 interface that contains the intact azurophilic granules were collected to detect primary antibodies by
SDS-PAGE electrophoresis and western immunoblotting with anti-rabbit IgG. Arrows point to MPO antibody that cofractionates with azurophilic granules.
(E) Intact azurophilic granules from naive neutrophils alone or treatedwith proteinase K (0, 1, 10, and 100 mg/ml) and immunoblotted forMPO, AZU, andBPI. Arrow
indicates the cleavage product of AZU.
888 Cell Reports 8, 883–896, August 7, 2014 ª2014 The Authors
Figure 4. H2O2 Drives the Dissociation of
the Azurosome
(A) NE release into the cytosol by untreated or
PEG-catalase-treated neutrophils at the indicated
time points, measured by proteolytic activity
against a chromogenic NE substrate, since cata-
lase interferes with the peroxide-based ELISA
readout. Data were normalized to the amount of
NE in the cytoplasm of each sample at the start of
the time course. Error bars indicate SD in triplicate
samples; ***p < 0.001 between 600 PMA untreated
versus catalase-treated triplicates.
(B) Immunoprecipitation from a control azurophilic
granule lysate with a-NE or a-MMP9 antibody
(mock), followed by immunoblotting against MPO.
Granules were left untreated or treated with H2O2
in the absence or presence of the protease in-
hibitors (PIs) NEi, CGi, PMSF and Roche cocktail,
or MPO inhibitor (ABAH). The input lysate prior to
immunoprecipitation is shown in the bottom lane.
(C) Immunoprecipitation from a control azurophilic
granule lysate, untreated or treated with H2O2,
using a a-NE antibody, followed by immunoblot-
ting against MPO, CG, AZU, or LYZ.
(D) Immunoprecipitation with anti-NE (IP a-NE)
from cytoplasmic neutrophil lysate of naive (N, 00)
or PMA-activated (NP, 600) control neutrophils.
Left lanes: total protein in the cytoplasmic lysate
before immunoprecipitation. Right lanes: proteins
immunoprecipitated with an a-NE antibody from
cytoplasm and immunoblotted with antibodies
against CG, AZU, or MPO. Images are from the
same exposed blot, but were separated to remove
irrelevant lanes.
(E) Single confocal microscopy sections of control
neutrophils stimulated with PMA for 60 min and
immunolabeled for CG (red) and NE (green). The
nucleus was labeled with the DNA stain Draq5
(blue). Arrows indicate nuclear NE and CG. Upper
panels: a neutrophil during the early stage of
NETosis. Lower panels: a neutrophil in a later
stage, exhibiting a large decondensed nucleus.
Scale bars, 10 mm. Right: quantitation of the per-
centage of neutrophils that contained more than
10% of total NE in the nucleus and the percentage
of nuclear NE that colocalized with CG. Error bars
indicate SD in duplicate samples.curve with an apparent cooperativity Hill coefficient of 2.78, sug-
gesting that approximately three complex molecules assemble
on the membrane to mediate calcein release. Notably, azuro-
some isolated from control human donors released calcein
approximately 40-fold more efficiently than azurosome isolated
from a DMPO donor, indicating that MPO is critical for the
release activity. Indeed, unlike azurocidin or NE (data not
shown), purified MPO was sufficient to release calcein, albeit
with 100-fold lower efficiency than the azurosome (Figure 5B).
Preboiling the complex completely abrogated calcein release,
indicating that the activity is mediated by proteins and not by re-
sidual detergent micelles (Figure 5A). The flowthrough from theazurosome purification did not induce release. We obtained
similar calcein release curves with a control complex purified
from azurophilic granules that were freeze-thawed and soni-
cated in the absence of detergent (Figure S5A). Impedance
measurements confirmed that unlike the detergent control, the
azurosome did not lyse liposomes (Figure 5C), indicating that it
promotes release without rupturing or dissolving membranes.
Adding purified MPO to the DMPO complex did not restore
calcein release (Figure S5B), suggesting that a functional azuro-
some requires a particular assembly.
To examine whether the control azurosome was sufficient to
mediate protein cargo release across native granulemembranes,Cell Reports 8, 883–896, August 7, 2014 ª2014 The Authors 889
Figure 5. The Azurosome Promotes Translocation across Granule Membranes
(A and B) Calcein release from synthetic PC/PS liposomes. Calcein fluorescence wasmeasured after 15min of incubation and normalized to liposomes alone and
liposomes permeabilized with NP-40. Error bars indicate SD in duplicate samples.
(A) Calcein release from synthetic liposomes incubated with control or DMPO azurosome, monitored by fluorescence dequenching of released calcein.
The azurosome was quantified based on NE content as measured by ELISA and expressed in moles (x axis). Black and white squares: flowthrough buffer
from the purification of control (black) and DMPO (white) azurosome. Black and white rhombuses: boiled samples (black) and DMPO azurosome (white)
(legend continued on next page)
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we incubated the complex with isolated specific and gelatinase
native granules, which do not contain the complex, and moni-
tored the release of LYZ from these granules into the soluble
fraction after separation by ultracentrifugation (Figure 5D). The
control azurosome mediated the release of significant levels
of LYZ from native granules as compared with the low levels
of the LYZ originating from the added control complex. In
contrast, no LYZwas released by theDMPO complex, indicating
that MPO is critical for the ability of the complex to translocate
proteins across intactmembranes.H2O2activates theproteolytic
activity of granule proteases in an MPO-dependent manner (Fig-
ure 2A). By testing fractions containing the purified azurosome,
we found that the complex was sufficient to trigger protease
activation (‘‘posttreated,’’ Figure S3F). Interestingly, treatment
with H2O2 or NEi did not affect calcein release (Figure S5C),
suggesting that translocation is not regulated by oxidation,
at least in vitro. In contrast, NE and AZU release from native
azurophilic granuleswasdependent onH2O2 stimulation (Figures
5E and 5F). The release of these proteases from azurophilic
granules was not blocked by NEi, indicating that oxidation
promotes protease release by triggering NE dissociation from
the complex without affecting the subsequent translocation
across the membrane and without requiring NE activity during
this step.
NE Regulates F-actin Dynamics during Translocation to
the Nucleus
Interestingly, during NETosis in response to C. albicans, the
neutrophils depolarized and rounded up (Figure 6A; Movie
S1). The timing of this global and abrupt downregulation of actin
dynamics immediately prior to nuclear decondensation promp-
ted us to ask whether it was linked to NE release. We previously
reported that blocking NE activity prevents the translocation of
NE to the nucleus (Papayannopoulos et al., 2010). To investi-
gate NE localization in the presence of NEi, we isolated cyto-
plasm from activated neutrophils and cleared the granules
and cytoskeleton by ultracentrifugation. We did not observe
any soluble NE in the cytosol of activated neutrophils, suggest-
ing that NE must be bound to an insoluble moiety (Figure 6B).
Upon close examination of activated neutrophils, we observed
that in the presence of NEi, NE failed to translocate to the nu-
cleus, but localized in the cytoplasm away from azurophilicat the highest concentration. Fitting was used to calculate the concentration o
coefficient (nH).
(B) Calcein release from synthetic liposomes incubated with control azurosome
based on MPO content as measured by ELISA and expressed in moles (x axis). F
release (R50).
(C) CASY impedance cell counter analysis of calcein-loaded synthetic PC/PS lipo
NP-40.
(D) Release of LYZ from specific and gelatinase granules incubated with control a
(S) and total (T) fractions by ultracentrifugation and immunoblotted against LYZ. C
LYZ from azurosomes alone.
(E) NE release by azurophilic granules as it was captured and detected by NE ELI
NEi and activated with 100 mMH2O2 for 30 min. Additional reactions in the same c
NE released. Error bars indicate SD in duplicate samples.
(F) AZU andMPO release from isolated native azurophilic granules alone or after in
for 30 min and insoluble granules were removed by centrifugation to yield solubl
See also Figures S4 and S5.granules (Figure 6A). In contrast to untreated activated cells
that appeared unpolarized, NEi-treated neutrophils remained
polarized and continued to chemotax, indicating ongoing actin
dynamics (Figures 6C and 6D). Strikingly, over time (2–3 hr),
these neutrophils developed unusually large filopodia, where
actin and NE colocalized (Figure 6D). This suggested that NE
blocks actin dynamics and that inhibition of NE activity drives
the accumulation of NE onto the actin cytoskeleton, preventing
NE from reaching the nucleus. To test this hypothesis, we incu-
bated purified NE with F-actin in the presence and absence of
NEi and examined their association by an F-actin sedimentation
assay. In the presence of NEi, purified NE bound to F-actin
filaments in vitro and was sequestered to the actin pellet after
cosedimentation occurred (Figure 6E). Strikingly, NE was pre-
sent in the soluble fraction only in the absence of NEi, while
some actin appeared degraded in the pellet. These data sug-
gest that NE binds to F-actin in the cytoplasm and must
degrade it in order to be free to translocate to the nucleus.
Accordingly, in neutrophils undergoing NETosis in response to
C. albicans, actin levels rapidly decreased by 30 min (the peak
of NE translocation; Figure 6F), but not in response to soluble
LPS, a weak inducer of NETosis. These findings expose an
additional role of the azurosome in regulating actin dynamics
through the modulation of NE proteolytic activity. This mecha-
nism of arresting chemotaxis may also serve to deploy NETs
in the vicinity of pathogens.
DISCUSSION
Our data suggest that resting neutrophils contain a subset of
azurophilic granules in which specific antimicrobial proteins
localize on the membrane (Figure 6G). Upon neutrophil stimula-
tion, the oxidative burst generates H2O2 that triggers the activa-
tion and dissociation of NE, CG, and AZU from a complex that
also contains MPO, LTF, PR3, and LYZ. We named this complex
the ‘‘azurosome’’ because it was isolated from azurophilic gran-
ules. The detailed mechanism by which ROS promote dissocia-
tion remains unclear and may involve a reaction with MPO or
other proteins of the complex. Importantly, MPO is required for
the release of the proteases across intact membranes through
a mechanism that remains to be elucidated. Once in the cyto-
plasm, NE binds the actin cytoskeleton and is sequestered inf azurosome required for 50% release (R50) and the apparent cooperativity
or purified MPO, monitored by fluorescence. The azurosome was quantified
itting was used to calculate the concentration of azurosome required for 50%
somes, either untreated or incubated with azurosome from a control donor or
zurosome, DMPO azurosome, or NP-40. Samples were separated into soluble
omplexes without granules were used as controls for the background levels of
SA. Duplicate reactions of intact azurophilic granules, untreated or treated with
onditions but treated with NP-40 were used for total to calculate the fraction of
cubationwith H2O2 in the absence or presence of NEi. Samples were incubated
e (S) protein. Total protein (T) prior to centrifugation.
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Figure 6. NE Regulates Actin Dynamics
during Translocation to the Nucleus
(A) Time lapse of live-cell microscopy depicting
neutrophils depolarizing prior to the onset of nu-
clear decondensation in response to C. albicans
(moi = 50). Scale bars, 10 mm.
(B) NE release by control neutrophils either left
naive or activated with PMA in the absence or
presence of NEi (+NEi). ***p < 0.001 comparing
control versus NEi-treated at 30 min and 60 min.
Error bars indicate SD in triplicate samples.
(C) Untreated and NEi-treated neutrophils immu-
nostained for NE (red), MPO (green), and DNA
(DAPI, blue) 60 min after PMA stimulation. Arrows
point to cytoplasmic areas containing NE in the
absence of MPO. Scale bars, 5 mm.
(D) Untreated and NEi-treated neutrophils immu-
nostained for F-actin (phalloidin, red), NE (green),
and DNA (DAPI, blue) 120 min after exposure to
C. albicans. Arrows point to areas where NE and
F-actin colocalize in the cytoplasm. Scale bars,
10 mm.
(E) NE binding to F-actin in vitro by cosedimenta-
tion, showing NE alone or treated with NEi in the
absence or presence of polymerized F-actin fila-
ments. Reactions were incubated for 30min at 37C
and centrifuged at 100,000 g to generate super-
natant containing soluble unbound protein super-
natant (Sup) and actin-bound pellet.
(F) Anti-Actin and anti-MPO immunoblots of whole-
cell extracts of naive neutrophils or stimulated with
LPS or C. albicans (moi = 10) at the indicated times
after activation.
(G) Mechanism of ROS-mediated NE translocation.
In resting neutrophils, azurosome complexes are
associated with a subset of azurophilic granule
membranes. Upon oxidative activation (1), H2O2
triggers the release and activation of NE/CG/AZU
protease complex into the cytoplasm (2). The
complex binds to F-actin (3). The degradation of
F-actin by active NE liberates the protease com-
plex, allowing it to enter the nucleus.the insoluble fraction of the cytoplasm. The activation of NE by
H2O2/MPO promotes F-actin degradation, liberating the prote-
ase to enter the nucleus.
Interestingly, the dissociation of the azurosome proteases
is regulated by oxidation. The subsequent translocation of
these proteases across the membrane is also mediated by
the azurosome, which can mediate the release of other granule
and liposome cargo constitutively in vitro. Our results sug-
gest that protease dissociation is an active process, whereas
crossing the membrane occurs passively. Translocation across
the membrane via the azurosome may be bidirectional, but
release may be driven entropically by a concentration gradient
from the granule, where the cargo is highly concentrated, to-
ward the cytosol, where cargo concentration is low. Interac-
tions with the actin cytoskeleton and chromatin on the other
side of the granule membrane may enhance this process
thermodynamically. The proteolytic activity of NE may allow
it to be liberated slowly from F-actin and enter the nucleus892 Cell Reports 8, 883–896, August 7, 2014 ª2014 The Authorsprogressively to process histones and accumulate by binding
tightly to the DNA. Accordingly, we find that during transloca-
tion, only 20%–40% of NE is soluble, indicating a slow tran-
sient process that is also reflected by immunofluorescence
microscopy.
The ability of the purified azurosome to release native granule
proteins without additional stimulation in vitro poses an inter-
esting problem, since it suggests that granule cargo would
be free to leak into the cytosol in naive neutrophils. As this is
likely not the case, additional regulatory mechanisms may exist
in vivo to prevent unregulated release. Notably, under naive
conditions, granule proteins are thought to be packed in a
semisolid state that may immobilize these proteins inside
the granule and prevent interactions with the azurosome and
subsequent translocation. However, more work is needed to
address these issues.
The ability of the complex to release calcein and granule pro-
teins when added exogenously to synthetic and native granules
without disrupting membrane integrity (Figures 4A, 4C, and 4E)
suggests that the azurosome incorporates into the lipid bilayer.
The complex may assemble to form either a pore or protein
transport machinery that transiently binds to cargo and rotates
within the bilayer to release it on either side of the membrane.
The cooperativity of the titration curve (Figure 4A) indicates
that multiple azurosome molecules must assemble for efficient
release. Multimerization is encountered in various pore-forming
proteins and ion channels (Anderluh and Lakey, 2010), but it
could also support a rotationmodel. Protein translocation across
the membrane is dependent on MPO protein (Figure 4A), but not
on MPO activity, as release of calcein and LYZ is greatly dimin-
ished in an MPO-deficient complex but is not affected by H2O2
stimulation (Figure 5C). Therefore, MPO is a key component
that allows transport of cargo across membranes. MPO has
also been shown to regulate neutrophil signaling via other
nonenzymatic mechanisms during its activation of macro-
phage-1 antigen (Mac-1) (El Kebir and Filep, 2013).
Our experiments suggest that complex dissociation may not
require the enzymatic activity of MPO either, since ABAH did
not block dissociation and HOCl was not sufficient to promote
it in vitro. However, these experiments should be considered
with caution because ABAH does not completely block the gen-
eration of HOCl, and exogenously added HOCl may not be
equivalent to the enzymatic product of MPO. Nevertheless, the
enzymatic activity of MPO and its products play an important
role in delivering NE to the nucleus, since the H2O2/MPO system
activates the proteolytic activity of NE (Figure 2A). Although
ABAH does not prevent NET formation, it slows down the pro-
cess (Metzler et al., 2011), likely due to the delayed degradation
of actin and histones. The azurosome-dependent protease acti-
vation highlights the importance of the complex as a protein
scaffold that confers temporal and spatial specificity to oxidative
signaling. ROS are highly reactive, short-lived molecules with
low target specificity. The association of proteases with MPO
allows theMPO/H2O2 system to specifically target the proteases
for activation. ROS are known to regulate a wide range of cellular
processes (Nathan, 2003; Tonks, 2005; Winterbourn, 2008)
and this paradigm may operate in other signaling pathways.
Inflammatory monocytes express MPO and are implicated in
cardiovascular disease (Sugiyama et al., 2001). MPO may form
complexes similar to the azurosome in these cells to regulate a
variety of processes.
Our data show that NE drives nuclear decondensation but is
also important for the disassembly of the actin cytoskeleton.
This step may serve to immobilize neutrophils and allow the pre-
cise deployment of NETs within the site of infection. Further-
more, the dismantling of the cytoskeleton may serve to facilitate
the disruption of the cytoplasmic membrane that precedes NET
release. The degradation of actin may serve to reduce danger-
associated actin signals during clearance of dying neutrophils
by dendritic and scavenger cells (Ahrens et al., 2012). In addition,
NE may degrade other proteins in the cytoplasm to affect addi-
tional neutrophil functions and the interaction with scavenging
macrophages that regulate the resolution of inflammation (Ser-
han and Savill, 2005).
Our findings highlight the sophisticated architecture of
neutrophil granules and suggest that distinct subsets of azuro-philic granules may have different functions. Notably, azuro-
some-containing granules are not impermeable membrane
compartments, but possess sophisticated machinery that medi-
ates the selective, regulated release of granule cargo delivered
through mechanisms that do not involve membrane fusion.
The mechanism of NE release shares similarities with models
that have been proposed to explain the release of cathepsins
from intact lysosomes and the permeabilization of mitochondrial
membranes during cell death (Boya and Kroemer, 2008). Bcl-2
proteins assemble on mitochondrial membranes and form
pores that allow the release of molecules larger than 100 kDa
without membrane rupture. Although some reports claim that
these Bcl-2 proteins assemble on lysosomal membranes during
apoptosis, it is not clear whether lysosomal protease release
involves a protein transporter, a pore-forming complex, or lysis
of a lysosome subpopulation. Importantly, ROS are important
mediators of lysosomal cathepsin release during necrosis, sug-
gesting that it may share functional similarities with NE release
during NETosis.
We found that the azurosome is important in NETosis, but
not during phagocytosis. This distinct role may be exploited
for treating human disease. Inhibitors of the azurosome could
potentially lead to therapies that inhibit NET formation specif-
ically without disrupting other neutrophil functions.EXPERIMENTAL PROCEDURES
NET Formation
Human neutrophils were isolated from peripheral blood as previously
described (Aga et al., 2002). We then seeded 5 3 104 neutrophils per well in
24-well tissue culture plates in 1 ml RPMI with 10 mM HEPES and 1% fetal
calf serum (FCS). Cells were allowed to settle at 37C for 1 hr in the presence
of a pharmacological inhibitor, when indicated, before stimulation with 100 nM
PMA (Sigma-Aldrich). NETs were formed 2–4 hr after PMA or C. albicans
(multiplicity of infection [moi] = 10) stimulation.
Endogenous Histone Degradation in Activated Neutrophils
For each sample, three wells containing 2 3 105 neutrophils were seeded
in six-well plates in 3 ml RPMI, 10 mM HEPES, 1% FCS (for naive cells
or PMA). Cells were stimulated with 100 nM PMA or plasma-opsonized
C. albicans (moi = 10). At the indicated time points, the medium was removed
and the cells were resuspended in 400 ml 13 Laemmli SDS buffer.
Subcellular Fractionation
Preparation of Neutrophil Lysates
For experiments measuring NE release into the cytosol, 8 3 106 neutrophils
were seeded in 10 cm dishes in RPMI, 10 mM HEPES, and 1% FCS. They
were allowed to settle for 30 min at 37C in the absence or presence of
20 mM NEi (GW311616A; Sigma-Aldrich), 20 mM CG inhibitor (CGi, 219372;
EMD), or 40 mg/ml PEG-catalase (C4963; Sigma-Aldrich), and then activated
with 100 nM PMA. At the indicated time points, cells were scraped into
500 ml cold granule prep buffer (GPB) (20 mM HEPES pH 7.4, 100 mM KCl,
100 mM sucrose, 3 mM NaCl, 3 mM MgCl2, 1 mM EGTA). Naive cells were
lysed by nitrogen cavitation at 400 psi for 2–3min and the nuclei were removed
by centrifugation at 300 3 g for 15 min to generate low-speed supernatant
(LSS). The LSS was centrifuged at 100,000 3 g for 1 hr to yield high-speed
supernatant (HSS).
Isolation of Granules
For granule preparations, LSS from 2–5 3 107 neutrophils/ml was centrifuged
(37,000 3 g, 20 min) over a discontinuous (1.050, 1.090, and 1.120 g/ml)
Percoll gradient as described previously (Kjeldsen et al., 1994; Lominadze
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Enzymatic Assays
NE was quantitated using an ELISA kit (Hycult Biotechnology) and enzymati-
cally by incubation with 300 mM Elastase Substrate I (MeOSuc-Ala-Ala-Pro-
Val-pNA; Calbiochem). Concentrations of H2O2 and HOCl were measured as
described previously (Morris, 1966; Noble and Gibson, 1970). MPO activity
was measured with 0.1 mg/ml O-phenylenediamine (Sigma-Aldrich) in the
presence of 500 mM H2O2.
Protease Activity Assays
H4 Substrate
LSS extracts from naive or PMA-activated neutrophils were incubated for 3 hr
with 5 mg/ml histone H4 (New England Biolabs) in the absence or presence of
0.2%NP-40 and then resolved by SDS-PAGE and immunoblotting against his-
tone H4.
b-galactosidase Substrate
Purified b-galactosidase (10 U/ml; Sigma-Aldrich) was added to granules
(30 mg/ml total protein) and incubated for 6–16 hr. Where noted, reactions
included 0.2% NP-40 (labeled as ‘‘detergent’’), 100 mM H2O2, 500 mM HOCl,
20 mM NEi, and/or 20 mM CGi. For colorimetric readout, 0.5 mg/ml
X-gal (5-bromo-4-chloro-indolyl-b-D-galactopyranoside; Sigma-Aldrich) was




Azurophilic granules or LSS in GPB were left untreated or treated with
100 mM H2O2 for 2 hr at 37
C. Where indicated, granules were first treated
with PIs (20 mM NEi, 20 mM CGi, 0.1 mM phenylmethanesulfonylfluoride
[PMSF], or cOmplete Protease Inhibitor Tablet; Roche) or with the MPO inhib-
itor ABAH at 500 mM for 30 min on ice. The granules were then solubilized
with 0.1% NP-40. Solubilized granules or LSS from 1 3 107 neutrophils
were incubated with 30 mg/ml rabbit anti-NE antibody (ab21595; Abcam) or
mock antibody (rabbit anti-MMP9, A0150 [Dako] or rabbit anti-BPI, B2188
[Sigma]) for 2 hr at 4C. Aliquots of total reactions were removed prior to
antibody addition.
Protein-G Ultralink resin (Pierce) slurry (10–15 ml) was then added and incu-
bated for 2 hr. Beads were rinsed three times in 1 ml GPB, three times in 1 ml
GPB + 0.5 U/ml heparin to remove nonspecific ionic binding (Figure S2D), and
then three times in 1 ml GPB. Bound proteins were eluted with 50 ml of 0.1 M
glycine (pH 2.7) and then 10 ml of 1 M HEPES (pH 7.4) was added to neutralize
the pH. Then 63 Laemmli sample buffer was added. Elutions and total reac-
tions were boiled and analyzed by SDS-PAGE electrophoresis and Coomassie
staining or immunoblotting.
Complex Purification
AZ granules, unactivated or preactivated with 100 mM H2O2 for 2 hr at 37
C,
were permeabilized with 0.1% NP-40. Then 2 ml of sample was loaded onto
a Superdex 200 GL column and eluted with 20 mM HEPES pH 7.4, 100 mM
NaCl, plus 0.5 U/ml heparin to prevent nonspecific ionic binding (Figure S2D).
For functional experiments, fractions containing the azurosome (usually 18–28)
were combined and concentrated over Amicon Ultracell 3k filters to approxi-
mately 5–10 mg/ml total protein concentration.
Protein Release
Release from Liposomes
Calcein-loaded liposomes were diluted into 200 ml osmo-PBS at 100 mM final
total lipid concentration in the presence or absence of the indicated protein or
azurosome concentrations.Where indicated, purifiedMPO (0.1–1 mM), 100 mM
H2O2, or 10 mMNEi was added to the reactions. Samples were left to incubate
for 10 min at 25C and calcein fluorescence was recorded. Duplicate and
triplicate samples were used for error calculation. After each read, 0.1% Triton
X-100 was added to each sample to obtain the 100% permeabilization values.
Data were normalized to the liposomes alone (lower limit) and liposomes in the
presence of Triton (maximum) measurements.
Release from Granules
For release from granules, 15 mg of a mixture of specific and gelatinase gran-
ules, isolated as described above, was incubated with azurosome containing
the equivalent of 50 nM NE (as measured by ELISA and semiquantitative894 Cell Reports 8, 883–896, August 7, 2014 ª2014 The Authorsimmunoblot) in the absence or presence of 1% NP-40 for 1.5 hr at 37C.
An aliquot of the total reaction (T) was removed and reactions were centri-
fuged at 100,000 3 g for 1 hr to yield the soluble fraction (S). Equivalent vol-
umes of S and T fractions were dissolved in 13 Laemmli SDS loading buffer.
The amount of LYZ or LTF in the azurosome alone control lanes was sub-
tracted from the experimental lanes. The amount of LYZ or LTF in each sol-
uble fraction was normalized to the total amount in the granules-alone
sample.
Azurophilic Granule-Antibody Interaction
Rabbit anti-MPO and rabbit anti-BPI (0.5 mg) were mixed with freshly prepared
azurophilic granules containing 30 mg total protein in 100 ml and incubated
30 min on ice. Reactions were overlaid over a 1.05, 1.09, and 1.12 mg/ml
discontinuous Percoll gradient in 13 GPB and centrifuged at 37,000 3 g for
20min. The soluble supernatant was collected, upper Percoll layers were aspi-
rated, and the 1.09/1.12 interface containing sedimented azurophilic granules
was isolated. Then 5 ml of the soluble supernatant and 30 ml of the azurophilic
fraction were analyzed by SDS-PAGE electrophoresis followed by western
immunoblotting with a horseradish peroxidase-conjugated anti-rabbit immu-
noglobulin G (IgG) antibody.
Proteinase K Protection Assay
LSS or azurophilic granules prepared by nitrogen cavitation of 43 106 neutro-
phils/ml in GPB were left untreated or pretreated with 0.2% Triton X-100 for
5 min at 37C, and then left untreated or treated with 1–100 mg/ml proteinase
K (Sigma-Aldrich) for 30 min at 37C. After the reactions, 1 mM PMSF was
added to inhibit proteinase K.
Degradation of S. flexneri IpaB by Neutrophils
S. flexneri M90T were cultured with 4.5 3 106 neutrophils in RPMI-HEPES
(moi = 30) in the absence or presence of 20 mM NEi and/or 500 mM of the
MPO inhibitor ABAH. At 15 min postinfection, the medium was removed
and cells were washed three times. At 90 min postinfection, the medium
was removed and samples were lysed into 400 ml Laemmli SDS loading buffer.
Assessment of Granule Integrity Using the CASY Impedance Cell
Counter
To assess granule integrity, 55 mg of azurophilic granules in 25 ml GPB, or 5 mg
of PC/PS liposomes in 200 ml buffer was either left untreated or treated with
100 mM H2O2, 10 mg/ml purified azurosome, or 0.2%–0.5% NP-40 for 90 min
at 37C. Thereafter, reactions were diluted into PBS and impedance was
measured using a CASY cell counter equipped with a 45 mM capillary.
Azurocidin Release
Azurophilic granules (50 mg total protein) were preincubated in the absence or
presence of 20 mM NEi on ice for 30 min. H2O2 (100 mM) was added to 300 ml
reactions and incubated for 30 min at 37C. Then 50 ml of the reaction was
removed for the total and the remaining reaction was centrifuged over a
1.050 g/ml Percoll layer at 37,000 3 g for 20 min to remove granules and
collect 50 ml of supernatant.
NE Release
Azurophilic granules in the presence of 10 mM NEi or vehicle (DMSO) were
placed in human NE ELISA wells (Hycult Biotech) and stimulated with
100 mM H2O2 or 100 and 500 mM HOCl for 30 min at 37
C in GPB. Duplicate
samples were used. For total samples, NP-40 was added prior to stimulation.
Supernatants were removed, wells were washed with ELISA wash buffer, and
NE protein released was detected with the ELISA kit.
F-actin Cosedimentation Assays
For F-actin cosedimentation assays, 0.5 mg/ml G-actin from rabbit muscle
was polymerized for 1 hr at room temperature in 200 ml of 5 mM Tris-HCl
pH 8.2, 50 mM KCl, 0.2 mM CaCl2, 1.2 mM ATP, 2 mM MgCl2, 0.5 mM dithio-
threitol. Then 100 ml containing 0.3 mg/ml NE was centrifuged at 100,000 3 g
for 20 min at 4C to remove aggregates. NEi was added to the supernatant
where indicated and mixed with 200 ml polymerized actin, yielding a final
NE concentration of 0.1 mg/ml. Reactions were incubated for 30 min at
37C and centrifuged at 100,000 3 g for 20 min at room temperature. The
supernatant was carefully removed and the pellet was resuspended in
300 ml buffer.
Live-Cell Microscopy
Neutrophils were incubated with heat-inactivated C. albicans (moi = 50) in the
presence of Sytox Green and imaged every 30 s for 4 hr by confocal micro-
scopy (six frames per second).
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